Hazlett, Burt & Watson’s iShares Biotechnology ETF IBB Stock Holding History

Hazlett, Burt & Watson’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$116K	Hold	609	–	–	0.03%	344
2026 Q1	$103K	Hold	609	–	–	0.03%	334
2025 Q4	$103K	Hold	609	–	–	0.03%	342
2025 Q3	$87K	Hold	609	–	–	0.03%	332
2025 Q2	$76K	Hold	609	–	–	0.03%	319
2025 Q1	$79K	Hold	609	–	–	0.04%	298
2024 Q4	$81K	Hold	609	–	–	0.04%	301
2024 Q3	$89K	Hold	609	–	–	0.04%	287
2024 Q2	$83K	Hold	609	–	–	0.04%	281
2024 Q1	$83K	Hold	609	–	–	0.05%	266
2023 Q4	$83K	Hold	609	–	–	0.06%	242
2023 Q3	$75K	Hold	609	–	–	0.06%	252
2023 Q2	$77K	Hold	609	–	–	0.06%	246
2023 Q1	$79K	Hold	609	–	–	0.06%	224
2022 Q4	$81K	Hold	609	–	–	0.07%	210
2022 Q3	$71K	Hold	609	–	–	0.07%	228
2022 Q2	$72K	Hold	609	–	–	0.07%	228
2022 Q1	$79K	Buy	+609	New	+$79.3K	0.06%	234

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Hazlett, Burt & Watson's IBB Position: Q2 2026 in Review

Hazlett, Burt & Watson held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 609 shares worth $116K. The position accounts for 0.03% of the portfolio, ranked #344.

Hazlett, Burt & Watson first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Hazlett, Burt & Watson held 609 shares of iShares Biotechnology ETF worth $116K as of Q2 2026.
Hazlett, Burt & Watson left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.03% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #344 holding.
Hazlett, Burt & Watson first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.